National Cancer Institute

June 8, 2017

Coffey lands major NCI award to support colorectal cancer research

Vanderbilt’s Robert Coffey Jr., M.D., has received an Outstanding Investigator Award from the National Cancer Institute (NCI) — more than $6.6 million over seven years — to support studies aimed at advancing the diagnosis and treatment of colorectal cancer (CRC), a leading cancer killer.

By Bill Snyder
February 2, 2017

National Cancer Institute’s Lowy details HPV virus research efforts

Douglas Lowy, M.D., acting director of the National Cancer Institute (NCI), warned that worldwide death rates from cervical cancer are expected to increase in low- and middle-income countries during the next 15 years unless steps are taken to prevent the cancer from occurring. Almost all cases of cervical cancer are linked to a viral infection.

By VUMC News and Communications
November 17, 2016

Graduate student’s cancer studies land NCI support

Kamakoti “Kami” Bhat, a fifth-year graduate student in the lab of David Cortez, Ph.D., professor of Biochemistry in the School of Medicine, has achieved a “first” for Vanderbilt University.

By Bill Snyder
Map of Socialist Republic of Vietnam through magnifying glass
October 6, 2016

Vanderbilt scientists to lead chronic disease research initiative in Vietnam

Scientists in the Vanderbilt Epidemiology Center (VEC) and Vanderbilt-Ingram Cancer Center (VICC) have been awarded a grant to plan and develop a Regional Center of Research Excellence in non-communicable diseases in Vietnam.

By VUMC News and Communications
African American woman looks up at sky
July 6, 2016

VICC researchers to study reasons for high breast cancer incidence and mortality rates among African-American women

A cancer research consortium headed by investigators at Vanderbilt-Ingram Cancer Center and two other institutions have received $12 million in federal funding to help determine why African-American women die at a higher rate and have more aggressive breast cancer than white women.

By VUMC News and Communications
October 29, 2015

Investigators find clues to melanoma treatment resistance

Nearly half of all patients with malignant melanoma, the most deadly form of skin cancer, have a mutation in the BRAF gene found in their tumors. Mutations in the BRAF gene turn on a cancer growth switch known as the MAP kinase pathway.

By VUMC News and Communications
September 17, 2015

Strong scores put VICC among top NCI centers

Vanderbilt-Ingram Cancer Center (VICC) has been recognized for the impact of its research programs and excellence in patient care by a panel of National Cancer Institute (NCI) reviewers, receiving an overall “exceptional” score as part of the renewal of the Cancer Center Support Grant (CCSG).
By VUMC News and Communications
August 13, 2015

Macara lands award to explore cancer cell behavior

Vanderbilt’s Ian Macara, Ph.D., has won an Outstanding Investigator Award from the National Cancer Institute (NCI) — nearly $6.6 million over seven years — to support the “unusual potential” of his research, which seeks to understand and predict cancer cell “behavior.”
By Bill Snyder
April 2, 2015

NCI’s national report shows cancer deaths on decline in U.S.

The death rates for most forms of cancer continue to decline at a modest pace among men, women and children in the United States, according to the Annual Report to the Nation on the Status of Cancer 1975 – 2011.
By VUMC News and Communications
March 26, 2015

Photo: Cancer discoveries

Louis Staudt, M.D., Ph.D., director of the National Cancer Institute (NCI) Center for Cancer Genomics and co-chief of the NCI’s Lymphoid Malignancies Branch, spoke about new lymphoma therapies at his recent Flexner Discovery Lecture.
By VUMC News and Communications
March 12, 2015

National Cancer Institute’s Staudt set for Discovery Lecture

Louis Staudt, M.D., Ph.D., a pioneer in gene expression profiling at the National Cancer Institute (NCI), will deliver the next Flexner Discovery Lecture on Thursday, March 19.
By Bill Snyder
November 14, 2013

National Cancer Institute director set for Discovery Lecture

The director of the National Cancer Institute, Harold Varmus, M.D., will deliver the next Flexner Discovery Lecture on Thursday, Nov. 21. His lecture, “New Directions in Cancer Research,” will begin at 4 p.m. in 208 Light Hall.
By Leigh MacMillan
February 28, 2013

Vaccination key to preventing HPV-related cancers

Vaccinating young males and females against several types of human papillomavirus (HPV) could dramatically reduce the incidence of HPV-related cancers worldwide, according to Douglas Lowy, M.D., deputy director of the National Cancer Institute.
By VUMC News and Communications
1 2 3 4 5